PRECLINICAL PUBLICATION · 2011

Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 21763290 ↗2011Reported benefit

RatChemical/toxinWistarMaleOral10-20 mg/kg

Model: Intra-colonic TNBS-induced colitis (Crohn's disease model)

Oral ellagic acid reduced colonic injury severity and inflammation in TNBS-induced rat colitis via MAPK and NF-kB pathway modulation.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.